Published on April 1, 2010 at 5:03 AM
XenaCare Holdings, Inc. (OTCBB:XCHO), a company specializing in the
marketing and retail distribution of consumer healthcare products, has
announced today that its over-the-counter (OTC) pain reliever, Cobroxin,
will be featured on a segment of The Balancing Act, a morning show that
airs on the top-rated women's cable television network, Lifetime
Television.
“We look forward to working closely with The Balancing
Act's hosts, Beth Troutman and Kristy Villa, to help continue to educate
viewers about Cobroxin and its added benefits over traditional pain
relievers”
"As the only morning show in the United States dedicated specifically to
educating, inspiring and empowering women, The Balancing Act reaches an
important segment of Cobroxin consumers," commented Frank Rizzo,
President and CEO of XenaCare
Holdings. "We look forward to working closely with The Balancing
Act's hosts, Beth Troutman and Kristy Villa, to help continue to educate
viewers about Cobroxin and its added benefits over traditional pain
relievers," he concluded.
The upcoming segment, slated to air on May 17, 2010, and May 31, 2010,
will feature an interview with Rik J Deitsch, the Chairman and CEO of Nutra
Pharma Corporation (OTCBB: NPHC), the company that developed and
currently manufactures Cobroxin. Additionally, it will explore the
benefits to using Cobroxin and showcase testimonials from Cobroxin users.
Source XenaCare Holdings